Publications by authors named "Eva Villamon"

Claim this Profile
P
Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols.
Neus Ruiz-Xivillé, Mireia Morgades, Laura Blanco, Dolors Costa, Blanca Espinet, Eva Villamon

Med Clin (Barc)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILING.
Álvaro Díaz González, Elvira Mora, Marta Garrote, Gonzalo Carreño-Tarragona, Marta Salido Galeote, Eva Villamon

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR7/8 ligands R848 and imiquimod induce differentiation of bone marrow cells from patients with myelodysplastic syndrome towards mature neutrophils.
Eva Villamón, Paula Guerrero, María Luisa Gil, Iván Martín, Paula Amat

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome.
Iván Martín Castillo, Elvira Mora, Rafael Hernani, Jose V Cervera, María J Fernandez

J Mol Diagn· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms.
Iván Martín Castillo, Eva Villamón, Marisa Calabuig, Irene Pastor, Blanca Ferrer-Lores

Br J Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel fusion gene in a myeloid/lymphoid neoplasm with rearrangement sensitive to specific inhibition.
Carlos Jiménez-Vicente, Marta Garrote, Mónica López-Guerra, Eva Villamón, Francesca Guijarro

Leuk Lymphoma· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Álvaro Díaz-González, Elvira Mora, Gayane Avetisyan, Santiago Furió, Rosalía De la Puerta

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.
Iván Martín, Eva Villamón, Rosario Abellán, Maria José Calasanz, Aroa Irigoyen

Br J Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Inge M Ambros, Gian-Paolo Tonini, Ulrike Pötschger, Nicole Gross, Véronique Mosseri, Eva Villamon

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
Alex Bataller, Guadalupe Oñate, Marina Diaz-Beyá, Francesca Guijarro, Ana Garrido, Eva Villamon

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine.
Iván Martín, Blanca Navarro, Alicia Serrano, Eva Villamón, Marisa Calabuig

Ann Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples.
Iván Martín, Blanca Navarro, Carlos Solano, Marisa Calabuig, Juan Carlos Hernández-Boluda

Anticancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model.
César Díaz-García, Sonia Herraiz, Esperanza Such, María Del Mar Andrés, Eva Villamón

Hum Reprod· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
Iván Martín, Blanca Navarro, Eva Villamón, Carlos Solano, Alicia Serrano

Exp Mol Pathol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines.
Eva Villamón, Javier González-Fernández, Esperanza Such, José Vicente Cervera, Daniel Gozalbo

Cancer Cell Int· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts.
Iván Martín, Esperanza Such, Blanca Navarro, Eva Villamón, Ana Vicente

Blood Cancer J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS).
Iván Martín, Esperanza Such, Blanca Navarro, Ana Vicente, María López-Pavía

Leuk Lymphoma· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.
Inés Gómez-Seguí, Dolors Sánchez-Izquierdo, Eva Barragán, Esperanza Such, Irene Luna

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.
Esperanza Such, Lourdes Cordón, Amparo Sempere, Eva Villamón, Mariam Ibañez

Ann Hematol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration.
Ana P Berbegall, Eva Villamón, Irene Tadeo, Tommy Martinsson, Adela Cañete

Neoplasia· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.
Irene Tadeo, Marta Piqueras, David Montaner, Eva Villamón, Ana P Berbegall

Pediatr Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.
Eva Villamón, Ana P Berbegall, Marta Piqueras, Irene Tadeo, Victoria Castel

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NeuPAT: an intranet database supporting translational research in neuroblastic tumors.
Eva Villamón, Marta Piqueras, Javier Meseguer, Ignacio Blanquer, Ana P Berbegall

Comput Biol Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New prognostic markers in neuroblastoma.
Samuel Navarro, Marta Piqueras, Eva Villamón, Yania Yáñez, Julia Balaguer

Expert Opin Med Diagn· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multilocus technique for risk evaluation of patients with neuroblastoma.
Inge M Ambros, Bettina Brunner, Gerhard Aigner, Clare Bedwell, Klaus Beiske, Eva Villamon

Clin Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis